Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideIDXXIdexx Laboratories
FinDog View：Bullish
| Metric | AMGN | IDXX |
|---|
| Close | 466.01 | 551.21 |
| Market Cap | $254B | $43.9B |
| 1M | +10.56% | +5.56% |
| P/E (TTM) | 28.5 | 38.9 |
| Forward P/E | 17.1 | 32.2 |
| P/E 5-Yr Percentile | 68 | 7 |
| P/S | 6.5 | 9.8 |
| P/B | 21.3 | 27.5 |
| Dividend Yield | 3.21% | — |
| Latest Quarter Revenue | $10.1B | $1.2B |
| Revenue YoY | +9.5% | +9.7% |
| Gross Margin | 72.0% | 64.0% |
| Latest Quarter EPS | 4.37 | 4.27 |
| Avg Post-Earnings Move | ±5.2% | ±1.8% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.08% | 2.68% |
| 90-Day Net Insider Buying | −$4.1M | −$1.2M |
AMGN · Revenue, Last 8 Quarters ($B)
IDXX · Revenue, Last 8 Quarters ($B)
